Inovio Pharmaceuticals, Inc. (INO) Financials

INO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 49.4 million 45.0 million
March 31, 2026 49.8 million 43.7 million
Dec. 31, 2025 74.3 million 50.2 million
Sept. 30, 2025 69.4 million 77.1 million

INO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -39.6 billion 1.5 billion
March 31, 2026 -21.6 million 698744
Dec. 31, 2025 -19.5 million 764561
Sept. 30, 2025 -21.6 million 757086

INO Net Income

No data available :(

INO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 36.7 million - 8.0 million
March 31, 2026 37.7 million - 8.7 million
Dec. 31, 2025 58.5 million - 9.4 million
Sept. 30, 2025 50.8 million - 7.3 million

INO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 81.6 million
March 31, 2026 69.1 million
Dec. 31, 2025 69.0 million
Sept. 30, 2025 52.2 million

INO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 4 10.8 million 7.8 million -
March 31, 2026 4 13.8 million 7.9 billion -
Dec. 31, 2025 127444 10.3 million 7.2 million -
Sept. 30, 2025 67951 13.3 million 7.9 million -

INO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 745464
Dec. 31, 2025 -65343 754054
Sept. 30, 2025 - 749656

INO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

INO

Price: $1.20

52 week price:
0.56
2.98

Payout Ratio Range:
-53.08%
1192438.73%

Earnings Per Share: -1.03 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 3.8 million

Ebitda: -28.0 million

Market Capitalization: 112.6 million

Links: